4-(chloromethyl)-1-methyl-1H-pyrazole hydrochloride, 95.0%, 5g

Matraces de fondo redondo de tres bocas con cuellos laterales paralelos, 3000 ml, 45/40, 29/32, 1 unidad

1-tert-Butyl 3-ethyl 3-benzylpiperidine-1,3-dicarboxylate, 95.0%, 10g

3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride>98.0%(HPLC)1g

Thiazole-2-carboximidamide hydrochloride, 95.0%, 25g

Methyl 3-bromo-6-methoxypicolinate, 97%, 5g

1-butil-1-metil-pirrolidinio, dicianamida, mínimo 98 %, 100 g, envase de vidrio

1-Bromo-2-fluoro-4-iodo-5-nitrobenzene, 95.0%, 5g

ETHYL 4-HYDROXYBUTANOATE, 95%, 250mg

4-Nitrobenzenesulfonyl fluoride, 95.0%, 5g

(imidazo[1,2-a]pyrimidin-2-ylmethyl)amine dihydrochloride hydrate, 95.0%, 10g

2-(4-Fluoronaphthalen-1-yl)propanoic acid, 95%, 250mg

Dimethyl Acetylenedicarboxylate>96.0%(GC)25mL